110013-21-3 Usage
General Description
Merafloxacin is a fluoroquinolone antibiotic used in veterinary medicine to treat bacterial infections in dogs and cats. It works by inhibiting the enzymes necessary for bacterial DNA replication, leading to bacterial cell death. Merafloxacin is effective against a wide range of gram-negative and gram-positive bacteria, including those that cause urinary tract infections, skin and soft tissue infections, and respiratory infections. It is typically administered orally or through injection and is generally well-tolerated by animals with few reported side effects. However, it is important to use Merafloxacin with caution and follow the instructions of a veterinarian to avoid the development of antibiotic resistance and potential harmful effects.
Check Digit Verification of cas no
The CAS Registry Mumber 110013-21-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,0,1 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 110013-21:
(8*1)+(7*1)+(6*0)+(5*0)+(4*1)+(3*3)+(2*2)+(1*1)=33
33 % 10 = 3
So 110013-21-3 is a valid CAS Registry Number.
InChI:InChI=1/C19H23F2N3O3/c1-3-22-8-11-5-6-24(9-11)17-14(20)7-12-16(15(17)21)23(4-2)10-13(18(12)25)19(26)27/h7,10-11,22H,3-6,8-9H2,1-2H3,(H,26,27)
110013-21-3Relevant articles and documents
1-Ethyl-7--1-pyrrolidinyl>-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid. New Quinolone Antibacterial with Potent Gram-Positive Activity
Domagala, John M.,Heifetz, Carl L.,Mich, Thomas F.,Nichols, Jeffry B.
, p. 445 - 448 (1986)
-
Process for quinoline-3-carboxylic acid antibacterial agents
-
, (2008/06/13)
An improved process for the preparation of 7-substituted amino-1-alkyl- or cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids is described where tetrafluorobenzoyl chloride is converted in three operations via 1-alkyl or 1-cycloalkyl-1
Antibacterial agents
-
, (2008/06/13)
Novel naphthyridine-, quinoline- and benzoxazine-carboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
